Safety and immunogenicity of a SARS-CoV-2 Gamma variant RBD-based protein adjuvanted vaccine used as booster in healthy adults
…, L Bruno, L Saposnik, M Salvatori… - Nature …, 2023 - nature.com
A Gamma Variant RBD-based aluminum hydroxide adjuvanted vaccine called ARVAC CG
was selected for a first in human clinical trial. Healthy male and female participants (18-55 …
was selected for a first in human clinical trial. Healthy male and female participants (18-55 …
Extraction-free protocol combining proteinase K and heat inactivation for detection of SARS-CoV-2 by RT-qPCR
…, BG Berardino, P Verneri, V Dansey, M Salvatori… - PLoS …, 2021 - journals.plos.org
Real-time reverse transcription PCR (RT-qPCR) is the gold-standard technique for severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detection in nasopharyngeal swabs …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detection in nasopharyngeal swabs …
Design, synthesis and biological evaluation of quinoxaline compounds as anti-HIV agents targeting reverse transcriptase enzyme
L Fabian, MT Porro, N Gomez, M Salvatori… - European Journal of …, 2020 - Elsevier
Infection by human immunodeficiency virus still represents a continuous serious concern and
a global threat to human health. Due to appearance of multi-resistant virus strains and the …
a global threat to human health. Due to appearance of multi-resistant virus strains and the …
A poor and delayed anti-SARS-CoV2 IgG response is associated to severe COVID-19 in children
…, M García, J Lattner, MJ Rolón, P Coll, M Salvatori… - …, 2021 - thelancet.com
Background Most children and youth develop mild or asymptomatic disease during severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, a very small …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, a very small …
Longitudinal study after Sputnik V vaccination shows durable SARS-CoV-2 neutralizing antibodies and reduced viral variant escape to neutralization over time
…, A Ceballos, V Ochoa, C Monzani, G Turk, M Salvatori… - Mbio, 2022 - Am Soc Microbiol
Recent studies have shown a temporal increase in the neutralizing antibody potency and
breadth to SARS-CoV-2 variants in coronavirus disease 2019 (COVID-19) convalescent …
breadth to SARS-CoV-2 variants in coronavirus disease 2019 (COVID-19) convalescent …
Persistence of SARS-CoV-2 RNA shedding and infectivity in immunized population: Prospective study along different epidemiological periods in Argentina
…, A Claps, M Nabaes Jodar, D Acuña, M Salvatori… - PLoS …, 2023 - journals.plos.org
During the pandemic of COVID-19, numerous waves of infections affected the two
hemispheres with different impacts on each country. Throughout these waves, and with the …
hemispheres with different impacts on each country. Throughout these waves, and with the …
Humoral response and neutralising capacity at 6 months post-vaccination against COVID-19 among institutionalised older adults in Argentina
…, J Marro, V Poncet, B Mazzitelli, M Salvatori… - Frontiers in …, 2022 - frontiersin.org
The COVID-19 pandemic has particularly affected older adults residing in nursing homes,
resulting in high rates of hospitalisation and death. Here, we evaluated the longitudinal …
resulting in high rates of hospitalisation and death. Here, we evaluated the longitudinal …
A novel bacterial protease inhibitor adjuvant in RBD-based COVID-19 vaccine formulations containing alum increases neutralizing antibodies, specific germinal …
…, J Alcain, I Mazzitelli, A Varese, M Salvatori… - Frontiers in …, 2022 - frontiersin.org
In this work, we evaluated recombinant receptor binding domain (RBD)-based vaccine
formulation prototypes with potential for further clinical development. We assessed different …
formulation prototypes with potential for further clinical development. We assessed different …
Longitudinal study after Sputnik V vaccination shows durable SARS-CoV-2 Neutralizing antibodies and reduced viral variant escape over time
…, A Ceballos, V Ochoa, C Monzani, G Turk, M Salvatori… - medRxiv, 2021 - medrxiv.org
Recent studies have shown a temporal increase in the neutralizing antibody potency and
breadth to SARS-CoV-2 variants in coronavirus disease 2019 (COVID-19) convalescent …
breadth to SARS-CoV-2 variants in coronavirus disease 2019 (COVID-19) convalescent …
A novel bacterial protease inhibitor adjuvant in RBD-based COVID-19 vaccine formulations increases neutralizing antibodies, specific germinal center B cells and …
…, J Alcain, I Mazzitelli, A Varese, M Salvatori… - bioRxiv, 2021 - biorxiv.org
In this work we evaluated recombinant receptor binding domain (RBD) based vaccine
formulation prototypes with potential for further clinical development. We assessed different …
formulation prototypes with potential for further clinical development. We assessed different …
